BDNF level role in formation of cognitive violations at middle-aged persons
https://doi.org/10.37489/2587-7836-2020-2-37-41
Abstract
Relevance: the problem of cognitive violations at middle-aged persons with stenoziruyushchy atherosclerosis of brakhiotsefalny arteries and interrelation between the BDNF level and cognitive violation at this group of persons is considered. Materials and methods: 50 patients whose average age 52 years with displays of stenoziruyushchy atherosclerosis of brakhiotsefalny arteries took part in research. The control group included 50 people with average age of 50 years without symptoms of atherosclerosis of brakhiotsefalny arteries. To all patients neuropsychological testing and research of the BDNF level was conducted. Results: on the basis of our supervision, it is expedient to consider the revealed features of cognitive violations at patients of middle age, haemo dynamic characteristics, level of maintenance of BDNF in blood plasma at dodementny stages of tserebrovaskulyarny frustration at inspection and planning of approaches to treatment of patients with this pathology.
About the Authors
E. G. Pepelyaev
FSBOU VO KemGMU Ministry of Health of Russia
Russian Federation
Russian Federation
Pepelyaev Evgeniy – graduate student of department of neurology, neurosurgery and medical genetics
Kemerovo
V. A. Semenov
FSBOU VO KemGMU Ministry of Health of Russia
Russian Federation
Russian Federation
Semenov Vladimir – DM, professor, manager of department of neurology, neurosurgery and medical genetics. SPIN code: 9741-3771
Kemerovo
O. A. Gromova
FSBOU VO IvGMA of the Ministry of Health of Russia
Russian Federation
Russian Federation
Gromova Olga – DM, professor of department of pharmacology with clinical pharmacology. SPIN code: 6317-9833
Ivanovo
References
1. Bogolepova AN, Chukanova EI. Problem of neuroplasticity in neurology. Zh Nevrol Psikhiatr Im SS Korsakov. 2010;110(8):72–75. (In Russ).
2. Gusev EI, Bogolepova AN. Cognitive violations at tserebrovaskulyarny diseases. Moscow: Medical press-inform; 2013. (In Russ).
3. Zakharov VV. All-Russia epidemiological and therapeutic investigation concerning cognitive impairment in the elderly ("Prometheus"). Neurological Journal. 2006;11(2):27–32. (In Russ).
4. Parfyonov WA, Zakharov VV, Preobrazhenskiy IS. Cognitive frustration. Moscow: Group remedium; 2014. (In Russ).
5. Starchina YuA, Parfyonov WA. Kognitivnye rasstrojstva pri cerebrovaskulyarnyh zabolevaniyah: diagnoz i lechenie. RMZh. Neurology. 2008;16(12):1–3. (In Russ).
6. Subbotin AV, Semenov WA, Getmanenko YM, et al. Diagnostics of cognitive violations at early stages of vascular diseases of a brain. Clinical neurology. 2009;(4):25–227. (In Russ).
7. Topchy NV, Movshich BL, Denisova NV. Vozmozhnosti vracha obshchej praktiki v profilaktike i lechenii cerebrovaskulyarnyh rasstrojstv. RMZh. Neurology. 2006;14(29):2065–2074. (In Russ).
8. Toole JF. Sosudistye zabolevaniya golovnogo mozga; rukovodstvo dlya vrachej. Moscow: GEOTARmedia; 2007. (In Russ).
9. Demencii: rukovodstvo dlya vrachej. Yakhno NN, Zakharov VV, Loshkina AB, Mkhitaryan EA. Moscow: MEDpress-inform; 2010. (In Russ).
10. Castren E, Võikar V, Rantamäki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol. 2007;7(1):18–21. DOI: 10.1016/j.coph.2006.08.009
11. Kuipers SD, Dramham CR. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel. 2006;9(5):580–586.
12. Leibrock J, Lottspeich F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 1989;34(6238): 149–152. DOI: 10.1038/341149a0
13. Martinowich K, Manjj H, Lu B. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 2007;10(9):1089–1093. DOI: 10.1038/nn1971
14. Pearse AG. The common peptides and the cytochemistry of their cells of origin. Basic Appl. Histochem. 1989;(24):63–73.
15. Petersen RS, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. JAMA Neurology. 1999;56(3): 303–308. DOI: 10.1001/archneur.56.6.760
16. Portet F, Ousset PJ, Visser PJ et al. Mild cognitive impairment (MCI) in clinical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI working group of the European consortium on Alzheimer’s disease. J Neurol Neurosurg Psychiat. 2006;77:714–718. DOI: 10.1136/jnnp.2005.085332
17. Waterhous EG, Xu B. New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci. 2009;42(2): 81–89. DOI: 10.1016/j.mcn.2009.06.009.
Review
For citations:
Pepelyaev E.G., Semenov V.A., Gromova O.A. BDNF level role in formation of cognitive violations at middle-aged persons. Pharmacokinetics and Pharmacodynamics. 2020;(2):37-41. (In Russ.) https://doi.org/10.37489/2587-7836-2020-2-37-41
Views:
623
Email this article 